Delivery or therapeutic capable agents

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20020082679A1
SERIAL NO

10002595

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A device and a method using the same, for reducing restenosis and hyperplasia after intravascular intervention. In particular, the present invention provides luminal prostheses which allow for controlled release of at least one therapeutic capable agent with increased efficacy to selected locations within a patient's vasculature to reduce restenosis. An intraluminal prosthesis may comprise an expandable structure and a source adjacent the expandable structure for releasing the therapeutic capable agent into the body lumen to reduce smooth muscle cell proliferation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AVANTEC VASCULAR CORPORATION870 HERMOSA AVENUE SUNNYVALE CA 94085

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Sirhan, Motasim Sunnyvale, CA 52 2297
Yan, John Los Gatos, CA 111 3544

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation